Introducing the new AltIndexLearn more
$00%
Total revenue, Q1 '26 ().

Did Hoth Therapeutics Beat Earnings?

Hoth Therapeutics (HOTH) reported Q1 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Hoth Therapeutics’s job postings, web traffic, and employee business outlook. See the full HOTH stock analysis or the earnings calendar for upcoming reports.

Hoth Therapeutics Quarterly Financial Trends ()

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Revenue
Gross margin
Operating margin
Net income-1.6M-2.1M-2.4M-3.5M-2.2M-4.1M-2.7M-2.7M
Net margin
EPS

Hoth Therapeutics Earnings Trend Analysis

Over the eight quarters from Q2 '24 to Q1 '26, Hoth Therapeutics’s quarterly revenue moved from $0 to $0.

When Is Hoth Therapeutics’s Next Earnings Date?

Hoth Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q1 '26. For the confirmed upcoming date — and every other company reporting soon — see the HOTH earnings calendar.

Frequently Asked Questions: Hoth Therapeutics Earnings

Hoth Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Hoth Therapeutics reported Q1 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the HOTH AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.